156 related articles for article (PubMed ID: 7083456)
1. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
Allen LM; Tejada F; Okonmah AD; Nordqvist S
Cancer Chemother Pharmacol; 1982; 7(2-3):151-6. PubMed ID: 7083456
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer.
Evans WE; Sinkule JA; Crom WR; Dow L; Look AT; Rivera G
Cancer Chemother Pharmacol; 1982; 7(2-3):147-50. PubMed ID: 7083455
[TBL] [Abstract][Full Text] [Related]
3. Human cytochrome P450 metabolism of teniposide and etoposide.
Relling MV; Evans R; Dass C; Desiderio DM; Nemec J
J Pharmacol Exp Ther; 1992 May; 261(2):491-6. PubMed ID: 1578365
[TBL] [Abstract][Full Text] [Related]
4. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
5. Current development of podophyllotoxins.
Canetta R; Hilgard P; Florentine S; Bedogni P; Lenaz L
Cancer Chemother Pharmacol; 1982; 7(2-3):93-8. PubMed ID: 7044596
[TBL] [Abstract][Full Text] [Related]
6. The clinical pharmacology of VM26 and VP16-213. A brief overview.
Creaven PJ
Cancer Chemother Pharmacol; 1982; 7(2-3):133-40. PubMed ID: 7044592
[No Abstract] [Full Text] [Related]
7. Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors.
Issell BF; Tihon C; Curry ME
Cancer Chemother Pharmacol; 1982; 7(2-3):113-5. PubMed ID: 7083450
[TBL] [Abstract][Full Text] [Related]
8. Uptake and binding of teniposide (VM26) in Krebs II ascites cells.
Hamza M; Canal P; Bugat R; Soula G; Douste-Blazy L
Biochem Pharmacol; 1987 May; 36(10):1599-603. PubMed ID: 3109424
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships among glycosidic derivatives of 4'-demethylepipodophyllotoxin and epipodophyllotoxin, showing VM26- and VP16-213-like activities.
Gupta RS; Chenchaiah PC; Gupta R
Anticancer Drug Des; 1987 Aug; 2(1):1-12. PubMed ID: 3449081
[TBL] [Abstract][Full Text] [Related]
10. Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems.
Gupta RS; Bromke A; Bryant DW; Gupta R; Singh B; McCalla DR
Mutagenesis; 1987 May; 2(3):179-86. PubMed ID: 3325741
[TBL] [Abstract][Full Text] [Related]
11. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1985 Jul; 45(7):3106-12. PubMed ID: 3839166
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients.
Rossi C; Zucchetti M; Sessa C; Urso R; Mangioni C; D'Incalci M
Cancer Chemother Pharmacol; 1984; 13(3):211-4. PubMed ID: 6488441
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of teniposide in patients with ovarian cancer.
D'Incalci M; Rossi C; Sessa C; Urso R; Zucchetti M; Farina P; Mangioni C
Cancer Treat Rep; 1985 Jan; 69(1):73-7. PubMed ID: 3967261
[TBL] [Abstract][Full Text] [Related]
14. The epipodophyllotoxin derivatives VM26 and VP16: experimental and clinical aspects.
Dombernowsky P; Hansen HH
Eur J Haematol Suppl; 1988; 48():49-57. PubMed ID: 3073960
[No Abstract] [Full Text] [Related]
15. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
[TBL] [Abstract][Full Text] [Related]
16. The clinical pharmacology of etoposide and teniposide.
Clark PI; Slevin ML
Clin Pharmacokinet; 1987 Apr; 12(4):223-52. PubMed ID: 3297462
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and efficacy of i.v. and i.p. VM26 chemotherapy in mice bearing Krebs II ascitic tumors.
Canal P; Bugat R; Rokoszak B; Berg D; Soula G; Roche H
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):765-71. PubMed ID: 3770034
[TBL] [Abstract][Full Text] [Related]
18. The podophyllotoxin derivatives VP16-213 and VM26.
Issell BF
Cancer Chemother Pharmacol; 1982; 7(2-3):73-80. PubMed ID: 7044593
[TBL] [Abstract][Full Text] [Related]
19. In vitro antitumor activity of teniposide against carcinoma of the lung in human tumor clonogenic assay.
Matsushima Y; Kanzawa F; Miyazawa N; Sasaki Y; Saijo N
Anticancer Res; 1986; 6(5):921-4. PubMed ID: 3026235
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of VP16 and VM26 in human brain tumors.
Zucchetti M; Rossi C; Knerich R; Donelli MG; Butti G; Silvani V; Gaetani P; D'Incalci M
Ann Oncol; 1991 Jan; 2(1):63-6. PubMed ID: 2009235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
